Moolec Science (MLEC) Common Equity (2022 - 2026)

Moolec Science (MLEC) has 5 years of Common Equity data on file, last reported at $11.3 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity changed N/A year-over-year to $11.3 million; the trailing twelve-month figure through Mar 2026 stood at $11.3 million (changed N/A YoY), and the FY2025 full-year result was -$67.4 million, down 5660.9% from the prior year.
• Common Equity grew to $11.3 million in Q1 2026, from $9.2 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $258.6 million in Q2 2023 to a low of -$67.4 million in Q2 2025.
• A 5-year average of $29.4 million and a median of $6.7 million in 2023 frame the typical range for Common Equity.
• Peak annual rise in Common Equity reached 229.56% in 2025, while the deepest fall reached 5660.9% in 2025.
• Tracing MLEC's Common Equity over 5 years: stood at $11.9 million in 2022, then tumbled by 43.82% to $6.7 million in 2023, then slumped by 58.16% to $2.8 million in 2024, then jumped by 229.56% to $9.2 million in 2025, then gained by 22.61% to $11.3 million in 2026.
• Business Quant data shows MLEC's Common Equity at $11.3 million in Q1 2026, $9.2 million in Q4 2025, and -$67.4 million in Q2 2025.